Dalian BIO-CHEM Future Growth
Future criteria checks 2/6
Dalian BIO-CHEM is forecast to grow earnings and revenue by 17.7% and 15.8% per annum respectively while EPS is expected to grow by 17.3% per annum.
Key information
17.7%
Earnings growth rate
17.3%
EPS growth rate
| Chemicals earnings growth | 30.4% |
| Revenue growth rate | 15.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Mar 2024 |
Recent future growth updates
No updates
Recent updates
These 4 Measures Indicate That Dalian BIO-CHEM (SHSE:603360) Is Using Debt Reasonably Well
Jun 12
Returns on Capital Paint A Bright Future For Dalian BIO-CHEM (SHSE:603360)
Apr 23Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement
Apr 01Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Mar 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1,508 | 486 | N/A | 442 | 1 |
| 12/31/2024 | 1,291 | 424 | N/A | 381 | 1 |
| 3/31/2024 | 1,146 | 354 | 151 | 223 | N/A |
| 12/31/2023 | 1,066 | 328 | 322 | 390 | N/A |
| 9/30/2023 | 1,104 | 349 | 372 | 433 | N/A |
| 3/31/2023 | 1,220 | 377 | 421 | 478 | N/A |
| 12/31/2022 | 1,257 | 403 | 346 | 480 | N/A |
| 9/30/2022 | 1,318 | 426 | 243 | 400 | N/A |
| 6/30/2022 | 1,192 | 355 | 41 | 240 | N/A |
| 3/31/2022 | 1,082 | 297 | 20 | 211 | N/A |
| 12/31/2021 | 1,006 | 250 | -50 | 142 | N/A |
| 9/30/2021 | 875 | 203 | -69 | 144 | N/A |
| 6/30/2021 | 827 | 217 | 13 | 207 | N/A |
| 3/31/2021 | 768 | 184 | -11 | 178 | N/A |
| 12/31/2020 | 750 | 222 | 101 | 211 | N/A |
| 9/30/2020 | 837 | 251 | 195 | 268 | N/A |
| 6/30/2020 | 920 | 322 | 201 | 254 | N/A |
| 3/31/2020 | 934 | 365 | 243 | 293 | N/A |
| 12/31/2019 | 872 | 307 | 177 | 240 | N/A |
| 9/30/2019 | 727 | 271 | 71 | 155 | N/A |
| 6/30/2019 | 626 | 195 | 47 | 145 | N/A |
| 3/31/2019 | 539 | 150 | 39 | 136 | N/A |
| 12/31/2018 | 528 | 145 | 47 | 135 | N/A |
| 9/30/2018 | 517 | 127 | 60 | 130 | N/A |
| 6/30/2018 | 471 | 109 | 46 | 93 | N/A |
| 3/31/2018 | 440 | 100 | 48 | 79 | N/A |
| 12/31/2017 | 410 | 100 | N/A | 76 | N/A |
| 9/30/2017 | 392 | 107 | N/A | 115 | N/A |
| 6/30/2017 | 393 | 109 | N/A | 132 | N/A |
| 3/31/2017 | 402 | 107 | N/A | 125 | N/A |
| 12/31/2016 | 389 | 98 | N/A | 120 | N/A |
| 9/30/2016 | 365 | 82 | N/A | 99 | N/A |
| 12/31/2015 | 328 | 57 | N/A | 74 | N/A |
| 12/31/2014 | 347 | 64 | N/A | 60 | N/A |
| 12/31/2013 | 291 | 49 | N/A | 54 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603360's forecast earnings growth (17.7% per year) is above the savings rate (2.9%).
Earnings vs Market: 603360's earnings (17.7% per year) are forecast to grow slower than the CN market (22.3% per year).
High Growth Earnings: 603360's earnings are forecast to grow, but not significantly.
Revenue vs Market: 603360's revenue (15.8% per year) is forecast to grow faster than the CN market (13.7% per year).
High Growth Revenue: 603360's revenue (15.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 603360's Return on Equity is forecast to be high in 3 years time